Shares of 5N Plus Inc. (OTCMKTS:FPLSF - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $6.56, but opened at $6.00. 5N Plus shares last traded at $6.00, with a volume of 103 shares.
5N Plus Price Performance
The company's 50-day moving average is $5.90 and its 200-day moving average is $5.07. The firm has a market capitalization of $627.01 million, a price-to-earnings ratio of 29.33 and a beta of 1.84. The company has a debt-to-equity ratio of 0.81, a current ratio of 3.54 and a quick ratio of 1.48.
5N Plus (OTCMKTS:FPLSF - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.12 earnings per share for the quarter, beating analysts' consensus estimates of $0.06 by $0.06. 5N Plus had a net margin of 6.94% and a return on equity of 18.49%. The company had revenue of $88.89 million for the quarter, compared to analyst estimates of $73.56 million.
About 5N Plus
(
Get Free Report)
5N Plus Inc produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells.
See Also
Before you consider 5N Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 5N Plus wasn't on the list.
While 5N Plus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.